MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2020

    A Case of Hemiballism Associated with Temporal Lobe Infarction

    B. Crispin, E. Mattos, R. Suarez, Y. Nuñez, C. Cosentino (Lima, Peru)

    Objective: To report a case of hemiballism associated with temporal lobe infarction. Background: Hemiballism is one of the most striking hyperkinesias seen in clinical practice.…
  • MDS Virtual Congress 2020

    Demonstrating the clinical value of MANAGE-PD tool in assessing symptom control of Parkinson’s disease patients: Evidence from G7 countries

    A. Antonini, P. Odin, A. Alobaidi, F. Cubillos, P. Schmidt, Y. Jalundhwala, K. Onuk, J. Zamudio, P. Kukreja, E. Jones, J. Wright, H. Fernandez (North Chicago, IL, USA)

    Objective: Evaluate the clinical value of using MANAGE-PD tool for assessing PD symptom control in real-world setting. Background: MANAGE-PD is a validated [1], web-based tool…
  • MDS Virtual Congress 2020

    Discriminating Essential and Dystonic Tremor using Video-based Time Series Analysis

    R. Stark, P. Fischer (Tübingen, Germany)

    Objective: Identify differences between ET and DT using video-based time series analysis of the fingertip. Background: Tremor types are classified based on clinical features and…
  • MDS Virtual Congress 2020

    Beyond Parkinson’s disease: the use of standardized speech, physical and occupational therapies for PD in atypical parkinsonisms, other movement disorders and aging conditions

    C. Fox, L. Guse, A. Halpern (Tucson, AZ, USA)

    Objective: 1) Examine how speech, physical and occupational therapists are using evidence-based, Parkinson’s specific treatments (LSVT LOUD and LSVT BIG) in atypical parkinsonisms, other movement…
  • MDS Virtual Congress 2020

    LSVT LOUD Applied to Adults with Cerebral Palsy: Two Single-Subject Studies

    G. Moya-Gale, J. Galgano, C. Ferrone, Y. Chang, G. Tsang, L. Ramig (Brooklyn, NY, USA)

    Objective: To examine treatment-related acoustic and perceptual changes after LSVT LOUD ® in two adult speakers with dysarthria secondary to cerebral palsy (CP). Background: Cerebral…
  • MDS Virtual Congress 2020

    Determinants of quality of life in a large, online cohort of patients with Parkinson’s disease

    M. Bock, E. Brown, C. Tanner (San Francisco, CA, USA)

    Objective: To investigate demographic differences and key determinants of quality of life (QOL) in a large, online cohort. Background: PD is a multisystem, progressive illness…
  • MDS Virtual Congress 2020

    Loneliness/Social Isolation as a Risk Factor for Worsened Parkinson Disease Severity

    I. Subramanian, L. Mischley, J. Farahnik (Los Angeles, CA, USA)

    Objective: The goal of this project was to evaluate the association between self-reported loneliness, quality of life, and patient-reported symptoms of Parkinson’s disease (PD) severity.…
  • MDS Virtual Congress 2020

    Sensory Trick in Oromandibular and Tongue Dystonia in Patient with Wilson’s Disease

    C. Shambetova (Bishkek, Kyrgyzstan)

    Objective: The aim of the case report is to demonstrate an unusual clinical feature of secondary dystonia. Background: A sensory trick (ST) is a voluntarily…
  • MDS Virtual Congress 2020

    Agreement Between Neurologists on UPDRS Scoring and Symptom Laterality

    E. Smith, J. Bertoni, D. Bhatti (Omaha, NE, USA)

    Objective: Assess inter-rater reliability and agreement on symptom laterality when the UPDRS is performed by two raters. Background: The United Parkinson’s Disease Rating Scale (UPDRS)…
  • MDS Virtual Congress 2020

    Perceptions of burden of spasticity and treatment satisfaction among post-stroke patients over the course of a botulinum neurotoxin A (BoNT-A) treatment cycle: An ethnographic study

    J. Jacinto, A. Lysandropoulos, A. Fulford-Smith (Estoril, Portugal)

    Objective: To design an ethnographic study following patients over a botulinum toxin type-A (BoNT-A) treatment cycle to inform individualized treatment. Background: The concept of individualized…
  • « Previous Page
  • 1
  • …
  • 99
  • 100
  • 101
  • 102
  • 103
  • …
  • 149
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley